ClinicalTrials.gg
Enrolling by invitationNCT07462338Updated Mar 10, 2026

Validity and Reliability of Timed Up and Go Test in Dual-Task Conditions for Multiple Sclerosis Patients

An observational study in Multiple Sclerosis, Reliability and Validity and Dual Task, sponsored by Sanko University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Sanko University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
50
Ages
18 Years to 65 Years
Sex
All
01

Study summary

his study aims to examine the validity and reliability of the Timed Up and Go (TUG) test in patients with Multiple Sclerosis (MS) under dual-task conditions, where participants perform both a motor and a cognitive task at the same time. MS affects movement, balance, and cognitive functions, which can lead to difficulties in walking and increased risk of falls.

In this study, volunteers with MS will be asked to perform the TUG test in different conditions:

Single-task TUG: walking, standing up, and sitting down without additional tasks.

Cognitive dual-task TUG: performing TUG while doing a cognitive task, such as counting backwards or word generation.

Motor dual-task TUG: performing TUG while carrying a small object on a tray.

Participants' demographic and clinical information will be recorded, and tests will be repeated to evaluate the reliability of the measurements. The results will help determine if the TUG test can reliably assess both motor and cognitive performance in MS patients.

The study is observational, and no experimental treatment will be given. Participation involves only performing tests and answering questions, taking approximately 25-30 minutes per session. All collected data will be kept confidential.

Read the detailed description

This study investigates the validity and reliability of the Timed Up and Go (TUG) test under dual-task conditions in patients with Multiple Sclerosis (MS). MS is a chronic neurological disease that affects motor and cognitive functions, often leading to walking difficulties, balance problems, and increased risk of falls.

Volunteers with MS will be recruited from the Neurological Rehabilitation Unit at SANKO University. Eligible participants will perform the TUG test in three conditions:

Single-task TUG: normal TUG without additional tasks.

Cognitive dual-task TUG (kSKYT): performing TUG while counting backwards in threes or generating words starting with a specific letter.

Motor dual-task TUG (mSKYT): performing TUG while carrying a small ball on a tray.

Participants' demographic and clinical data, including age, sex, height, weight, MS duration, EDSS score, and history of falls, will be recorded. TUG tests will be conducted by two physiotherapists and repeated after one week to assess test-retest reliability and inter-rater reliability.

Convergent validity will be evaluated by comparing dual-task TUG results with single-task TUG, 25-step walking test, Mini-BESTest, and a dual-task questionnaire. Known-groups validity will be assessed by comparing results between MS patients who have fallen and those who have not.

All data will be coded and stored confidentially. The study is observational, with no experimental interventions, and each assessment session will take approximately 25-30 minutes.

02

Conditions studied

  • Multiple Sclerosis
  • Reliability and Validity
  • Dual Task

Browse trials for

Keywords

  • multiple sclerosis
  • reliability and validity
  • dual task
03

In context

Multiple Sclerosis

3,264 studies on the registry are indexed under Multiple Sclerosis; 659 are open to participants now.

This study's planned enrollment of 50 is below the median of 100 across 970 observational studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Sanko University is the lead sponsor of 52 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

multiple sclerosis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with Multiple Sclerosis (MS).
  • Age 18 years or older.
  • EDSS score low to moderate (able to walk without assistive devices).
  • Willing to provide .
  • Able to perform Timed Up and Go (TUG) test.

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment preventing understanding of instructions.
  • Recent MS relapse (within the past 30 days).
  • Use of walking aids that interfere with TUG test performance.
  • Other neurological or musculoskeletal conditions affecting walking or balance.
  • Any condition that makes participation unsafe, according to the investigato
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Multiple Sclerosis Patients Observed for Dual-Task TUG Test

    This cohort includes volunteers diagnosed with Multiple Sclerosis (MS) who will participate in observational assessments of functional mobility using the Timed Up and Go (TUG) test under single-task and dual-task conditions. No experimental interventions will be applied. Participants will perform cognitive and motor dual-tasks simultaneously with the TUG test to evaluate walking, balance, and functional mobility. Demographic and clinical data, including age, sex, MS duration, EDSS score, and fall history, will be recorded. The cohort will be assessed by trained physiotherapists to determine test-retest and inter-rater reliability, as well as validity of the dual-task TUG test.

06

What researchers measure

Primary outcomes

  1. Sit-to-Stand and Walk Test (SKYT)

    SKYT is a test that assesses an individual's functional mobility, balance, and walking performance, including sitting, standing up, walking, turning, and sitting back down. The participant is asked to walk 3 metres and

    Time frame: 1 week

  2. Dual-task SKYT tests

    Dual-task SKYT tests will consist of three different dual-task SKYT tests: two cognitive dual-task SKYT tests (cSKYT) and one motor dual-task SKYT test (mSKYT). The cognitive task parameters of the cSKYT will be numerical processing

    Time frame: one weeks

  3. The 25-step walk test (S25AYT)

    This is a standardised test used to assess walking speed and functional mobility in MS patients, performed by walking a distance of 7.62 metres as quickly and safely as possible. The test has been reported to have high rel

    Time frame: one weeks

  4. Dual-task questionnaire

    The questionnaire was originally developed to assess individuals with neurological injury or disease and is used to evaluate the frequency of difficulties experienced in daily activities involving dual tasks. The questionnaire consists of 10 items, and each question is rated on a 5-point scale (0 = 'never' to 4 = 'very often' or N/A = 'not applicable'). The resulting score is the average score per question (questionnaire score = total questionnaire score/10). Its validity and reliability in the Turkish MS population have been demonstrated.

    Time frame: one weeks

  5. Mini-BESTest

    A test frequently used in neurological disease populations that assesses the dynamic components of balance control. Participants are asked to perform various balance tasks (e.g., postural responses, sensorimotor strategies, dynamic walking). Studies conducted in MS patients have demonstrated that the Mini-BESTest has high reliability and validity in the Turkish neurological population, including MS.

    Time frame: one weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07462338
Lead sponsor
Sanko University
Responsible party
Hakan Polat (dırector, Sanko University) — Principal investigator
First posted
Mar 10, 2026
Start date
Feb 15, 2026
Primary completion
Mar 15, 2026 (estimated)
Completion
Apr 1, 2026 (estimated)
Last update
Mar 10, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion